Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Cavitation-based bio-ablation and drug delivery

Project description

Improving medical sound wave therapies

Medical sound wave therapies are used to treat neurological diseases, tumours, blood clots, bacterial infections, and kidney stones. However, further advancements in their medical applications are needed. The ERC-funded CAVIAR project will enhance the medical use of high-intensity focused sound waves, specifically ultrasound and shock waves. It will clarify the physics underlying ultrasound, microbubble-mediated targeted drug delivery, and non-thermal cavitation-based ablation of biological tissues and stones. Through in vitro experiments, the project will explore the mechanisms of mechanical bioeffects produced by cavitation under various acoustic conditions, from gentle ultrasound for reversible cellular sonopermeabilisation to stone fragmentation in shock wave lithotripsy. The anticipated outcomes will improve the safety, precision, and efficacy of medical sound wave therapies.

Objective

The proposed research will critically advance the medical use of high-intensity focused sound waves, namely ultrasound and shock waves. In particular, the project aims to break grounds by elucidating the physics behind ultrasound and microbubble-mediated targeted drug delivery and non-thermal, cavitation-based ablation of biological tissues and stones, relevant in the treatments of neurological diseases, tumours, blood clots, bacterial infections and kidney stones. Through carefully designed in-vitro experiments, the project aims at explaining and comprehensively characterising, uniquely within a single framework, the currently elusive mechanisms behind the mechanical bioeffects produced by cavitation activity across a wide range of acoustic driving conditions from gentle, low-amplitude ultrasound for reversible cellular sonopermeabilisation to drugs up to the fragmentation of stones in shock wave lithotripsy. This will be achieved using a unique combination of advanced measurement techniques such as ultrafast videomicroscopy and synchrotron X-ray imaging, and leveraging the PI's expertise in acoustics, microbubble technology and the physics of cavitation.

The expected outcomes of the proposed research are to i) help optimise the mechanical effects in medical sound wave therapies to improve their safety, precision and efficacy and allowing swift clinical translation for emerging medical therapies; ii) significantly advance experimental techniques to spatiotemporally resolve ultrafast microevents; iii) refine acoustic cavitation detection techniques in the clinical setting by correlating specific visually observed cavitation activities to their acoustic signatures; and iv) propose a new, rigorous measure to assess safety against mechanical bioeffects caused by cavitation in clinical applications using high-amplitude sound waves.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-STG

See all projects funded under this call

Host institution

EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH
Net EU contribution
€ 2 069 415,00
Address
Raemistrasse 101
8092 Zuerich
Switzerland
Region
Schweiz/Suisse/Svizzera Zürich Zürich
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 2 069 415,00

Beneficiaries (1)